Rhythm Pharmaceuticals
RYTM
RYTM
143 hedge funds and large institutions have $1.56B invested in Rhythm Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 12 closing their positions.
Holders
143
Holders Change
+27
Holders Change %
+23.28%
% of All Funds
2.28%
Holding in Top 10
7
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+133.33%
% of All Funds
0.11%
New
39
Increased
48
Reduced
39
Closed
12
Calls
$10.9M
Puts
$1.32M
Net Calls
+$9.63M
Net Calls Change
+$6.03M
Top Buyers
| 1 |
CC
1
Commodore Capital
New York
|
$47.6M |
| 2 |
O
2
OrbiMed
New York
|
$13.4M |
| 3 |
LGM
3
Logos Global Management
San Francisco,
California
|
$9.17M |
| 4 |
PA
4
Perceptive Advisors
New York
|
$8.73M |
| 5 |
5
Morgan Stanley
New York
|
$10M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EFM
151
E Fund Management
Guangzhou,
China
| – | -$230K | -13,948 | Closed |
|
|
VF
152
Virtu Financial
New York
| – | -$217K | -13,188 | Closed |
|
|
HP
153
Harbourvest Partners
Boston,
Massachusetts
| – | -$93K | -5,639 | Closed |
|
154
Russell Investments Group
London,
United Kingdom
| – | -$18.1K | -1,100 | Closed |
|
|
BHWM
155
Beaird Harris Wealth Management
Dallas,
Texas
| – | -$809 | -49 | Closed |
|